In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours

By Sato Y.   Kashimoto S.   MacDonald J.R.   Nakano K.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1419-1428

Elsevier

Access to resources Recommend Favorite

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model

By Hammond L.A.   Hilsenbeck S.G.   Eckhardt S.G.   Marty J.   Mangold G.   MacDonald J.R.   Rowinsky E.K.   Von Hoff D.D.   Weitman S.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2430-2436

Elsevier

Access to resources Recommend Favorite

The Influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts

By Boven E.   Jansen W.J.M.   Hulscher T.M.   Beijnen J.H.   van Tellingen O.  

European Journal of Cancer, Vol. 35, Iss. 5, 1999-05 ,pp. : 840-849

Elsevier

Access to resources Recommend Favorite

Temozolomide Reduces the Metastatic Potential of Lewis Lung Carcinoma (3LL) in Mice: Role of -6 Integrin Phosphorylation

By Tentori L.   Leonetti C.   Aquino A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 746-754

Elsevier

Access to resources Recommend Favorite

Interleukin15: A potent adjuvant enhancing the efficacy of an autologous wholecell tumor vaccine against Lewis lung carcinoma

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1828-1834

Spandidos Publications

Access to resources Recommend Favorite